Stockscreener 앱 받기
98.68
0.39%
-0.39
시간 외 거래:
98.90
0.22
+0.22%
전일 마감가:
$99.07
열려 있는:
$96.98
하루 거래량:
598.41K
Relative Volume:
0.55
시가총액:
$23.72B
수익:
$2.97B
순이익/손실:
$-812.83M
주가수익비율:
-29.06
EPS:
-3.3962
순현금흐름:
$-1.24B
1주 성능:
+6.37%
1개월 성능:
-14.06%
6개월 성능:
-12.77%
1년 성능:
-0.32%
1일 변동 폭
$96.38
$98.88
1주일 범위
$94.30
$104.56
52주 변동 폭
$76.53
$131.49
바이오앤테크 Stock (BNTX) Company Profile
BNTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNTX
Biontech Se Adr
|
98.68 | 22.30B | 2.97B | -812.83M | -1.24B | -3.3962 |
|
ONC
Beigene Ltd Adr
|
241.43 | 27.03B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
436.00 | 112.64B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.335 | 40.86M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.34 | 64.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
75.06 | 6.07B | 0 | -153.72M | -103.81M | -2.00 |
바이오앤테크 Stock (BNTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 개시 | Citigroup | Buy |
| 2025-01-10 | 개시 | Truist | Buy |
| 2024-12-11 | 개시 | Wells Fargo | Overweight |
| 2024-12-02 | 재확인 | BMO Capital Markets | Outperform |
| 2024-11-19 | 개시 | Berenberg | Buy |
| 2024-11-19 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-11-08 | 업그레이드 | Goldman | Neutral → Buy |
| 2024-09-24 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-17 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-16 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-08-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-08-02 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-05-14 | 개시 | Evercore ISI | In-line |
| 2024-02-23 | 개시 | BMO Capital Markets | Outperform |
| 2024-01-05 | 개시 | Oppenheimer | Perform |
| 2023-12-01 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-10-16 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-05-17 | 업그레이드 | Redburn | Neutral → Buy |
| 2022-12-15 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-17 | 개시 | Cowen | Market Perform |
| 2022-07-13 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-07-06 | 재개 | Canaccord Genuity | Buy |
| 2022-02-01 | 업그레이드 | Redburn | Sell → Neutral |
| 2021-12-16 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2021-10-22 | 개시 | Deutsche Bank | Hold |
| 2021-10-07 | 개시 | Jefferies | Hold |
| 2021-08-11 | 업그레이드 | Bryan Garnier | Neutral → Buy |
| 2021-07-19 | 재개 | Wolfe Research | Outperform |
| 2021-06-16 | 다운그레이드 | Redburn | Neutral → Sell |
| 2021-05-18 | 개시 | Goldman | Neutral |
| 2021-05-11 | 다운그레이드 | Bryan Garnier | Buy → Neutral |
| 2020-12-01 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-08-03 | 재개 | Berenberg | Buy |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-30 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-05-19 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-04-28 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2020-03-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-03-09 | 개시 | H.C. Wainwright | Neutral |
| 2020-01-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-01-22 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-11-05 | 개시 | Wolfe Research | Outperform |
| 2019-11-04 | 개시 | Berenberg | Buy |
| 2019-11-04 | 개시 | BofA/Merrill | Buy |
| 2019-11-04 | 개시 | Canaccord Genuity | Buy |
| 2019-11-04 | 개시 | JP Morgan | Overweight |
| 2019-11-04 | 개시 | SVB Leerink | Outperform |
| 2019-11-04 | 개시 | UBS | Buy |
모두보기
바이오앤테크 주식(BNTX)의 최신 뉴스
MRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 Shots - Zacks Investment Research
BioNTech to invest up to £1bn in UK R&D expansion - Sharecast.com
Bybit Gold & FX now supports stock trading: Explore new markets! - Bybit Announcement
BioNTech SE ADR (NASDAQ: BNTX): Getting A Free Pass? - Stocksregister
Balance Sheet Breakdown: BioNTech SE ADR (BNTX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Why BioNTech Stock Got Trounced on Tuesday - The Motley Fool
Why BioNTech Stock Got Trounced On Tuesday - Barchart.com
BioNTech SE Reports Q1 2025 Financial Results - TipRanks
BioNTech’s Earnings Call: Oncology Progress Amid Financial Challenges - TipRanks
BioNTech SE ADR [NASDAQ: BNTX] Sees Increase in Stock Value - knoxdaily.com
HRL Shares Experience Surge in Value - knoxdaily.com
Nordson Corp [NDSN] stock for 268,620 USD was sold by Lovass Stephen - knoxdaily.com
Hanesbrands Inc [HBI] Records 200-Day SMA of $6.81 - knoxdaily.com
Ratio Review: Analyzing Regency Centers Corporation (REG)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Financial Metrics Exploration: Understanding MARA Holdings Inc (MARA) Through Ratios - DWinneX
Financial Fitness Check: Examining BioNTech SE ADR (BNTX)’s Key Ratios - DWinneX
The growth track for BioNTech SE ADR (BNTX) has changed recently - Sete News
Financial Health Report: Arthur J. Gallagher & Co (AJG)’s Ratios Tell a Tale - DWinneX
Financial Fitness Check: Examining B. Riley Financial Inc (RILY)’s Key Ratios - DWinneX
Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales - sharewise
A year in review: BioNTech SE ADR (BNTX)’s performance in the last year - uspostnews.com
BioNTech SE ADR (NASDAQ: BNTX) Could Make Significant Gains? - Marketing Sentinel
Investors Could Make -86.23% On NOV Inc (NYSE: NOV) Stock - Marketing Sentinel
Let’s Start With The Stock Forecast For UroGen Pharma Ltd (NASDAQ: URGN) - Marketing Sentinel
Is Murphy Oil Corp (NYSE: MUR) Stock Set To Rise More? - Marketing Sentinel
Why Is Summit Therapeutics Stock Trading Higher On Monday? - Benzinga
BioNTech SE ADR (BNTX) Stock: A Year of Market Fluctuations - investchronicle.com
Faraday Future Intelligent Electric Inc (FFAI) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com
Community Health Systems, Inc Inc. (CYH) Price Performance: A Comparative Analysis with Competitors - investchronicle.com
Checking in on BioNTech SE ADR (BNTX) after recent insiders movement - knoxdaily.com
Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season? - Yahoo Finance
BioNTech SE ADR [BNTX] Shares Jump Approximately 32.28% Over the Year - knoxdaily.com
Today’s watch list includes BioNTech SE ADR (NASDAQ:BNTX) stock - uspostnews.com
AMKOR Technology Inc [AMKR] Records 200-Day SMA of $26.99 - knoxdaily.com
Fluence Energy Inc [FLNC] Officer makes an insider purchase of 78,258 shares worth 0.29 million. - knoxdaily.com
Immunovant Inc [IMVT] Records 50-Day SMA of $18.03 - knoxdaily.com
It makes sense and dollars to buy BioNTech SE ADR (BNTX) stock - Sete News
Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains? - Yahoo Finance
BioNTech Surges On Summit's Coattails. But Can They Take On Merck? - Investor's Business Daily
Hewlett Packard Enterprise Co (HPE): What Are The Positives? - Marketing Sentinel
MARA Holdings Inc (MARA) Is A Buy Stock For Small Caps – Analysts - Marketing Sentinel
Stocks With Rising Relative Strength: BioNTech ADR - Investor's Business Daily
BioNTech, Pfizer report good news from vaccine trial - Morningstar
Century Aluminum Co [CENX] Stock sold by Insider Hoffman Robert F for $0.1 million - knoxdaily.com
Strength Seen in BioNTech (BNTX): Can Its 6.0% Jump Turn into More Strength? - Yahoo Finance
Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last? - Yahoo Finance
Here's Why Summit Therapeutics Stock Soared 15% on Friday - Zacks Investment Research
Pfizer Stock Falls To New 52-Week Low: Should You Buy The Dip? - Barchart.com
CureVac’s amended patent upheld by European Patent Office - Investing.com
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
BioNTech’s Earnings Call: Oncology Growth Amidst Challenges - TipRanks
바이오앤테크 (BNTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
17.27%
1.06%
자본화:
|
볼륨(24시간):